Cognizant Tech Solns (NASDAQ:CTSH) has outperformed the market over the past 20 years by 12.29% on an annualized basis producing an average annual return of 19.09%. Currently, Cognizant Tech Solns has a market capitalization of $36.48 billion.
Pulse Biosciences, Inc. (NASDAQ:PLSE), a novel bioelectric medicine company developing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced receipt of U.S. Food and